A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk

Anni Moore, Sara Bandres-Ciga, Cornelis Blauwendraat, Monica Diez-Fairen on behalf of the International Parkinson’s Disease Genomics Consortium (IPDGC)
doi: https://doi.org/10.1101/2021.03.08.21252688

Article usage

Article usage: March 2021 to July 2025

AbstractFullPdf
Mar 20214921265
Apr 20217724
May 20216038
Jun 202155111
Jul 20213517
Aug 202173610
Sep 202132523
Oct 202139224
Nov 202131423
Dec 202131110
Jan 20221972
Feb 20221754
Mar 20222606
Apr 20222434
May 20221727
Jun 202232366
Jul 202219153
Aug 202225110
Sep 202233010
Oct 20221505
Nov 20221623
Dec 20221607
Jan 20232626
Feb 20232131
Mar 20232335
Apr 20231912
May 20231326
Jun 20232154
Jul 2023511
Aug 2023271215
Sep 20231755
Oct 2023711
Nov 20231324
Dec 20231803
Jan 20241004
Feb 20242225
Mar 2024714
Apr 20241034
May 20241247
Jun 2024722
Jul 2024836
Aug 2024316
Sep 20241229
Oct 202412116
Nov 20241016
Dec 20242217
Jan 20251225
Feb 20251413
Mar 20251777
Apr 202512011
May 202517810
Jun 2025331416
Jul 2025355
Back to top
Posted March 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk
Anni Moore, Sara Bandres-Ciga, Cornelis Blauwendraat, Monica Diez-Fairen
medRxiv 2021.03.08.21252688; doi: https://doi.org/10.1101/2021.03.08.21252688
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area